Retraction Note : Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer
| Errataetall: |
RetractionOf: Oncogene. 2014 Oct 16;33(42):4985-96. - PMID 24166501 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Oncogene - 43(2024), 15 vom: 06. Apr., Seite 1160 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zheng, X Q [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 25.04.2024 published: Print RetractionOf: Oncogene. 2014 Oct 16;33(42):4985-96. - PMID 24166501 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41388-024-02983-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368862763 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368862763 | ||
| 003 | DE-627 | ||
| 005 | 20240425232949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41388-024-02983-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM368862763 | ||
| 035 | |a (NLM)38396296 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zheng, X Q |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retraction Note |b Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a RetractionOf: Oncogene. 2014 Oct 16;33(42):4985-96. - PMID 24166501 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Retraction of Publication | |
| 700 | 1 | |a Guo, J P |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, H |e verfasserin |4 aut | |
| 700 | 1 | |a Kanai, M |e verfasserin |4 aut | |
| 700 | 1 | |a He, L L |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Y Y |e verfasserin |4 aut | |
| 700 | 1 | |a Koomen, J M |e verfasserin |4 aut | |
| 700 | 1 | |a Minton, S |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, M |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, X B |e verfasserin |4 aut | |
| 700 | 1 | |a Coppola, D |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, J Q |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncogene |d 1990 |g 43(2024), 15 vom: 06. Apr., Seite 1160 |w (DE-627)NLM012595683 |x 1476-5594 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2024 |g number:15 |g day:06 |g month:04 |g pages:1160 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41388-024-02983-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2024 |e 15 |b 06 |c 04 |h 1160 | ||